CVS Health announces quarterly dividend
Get Alerts CVS Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3.3%
EPS Growth %: +1.1%
Join SI Premium – FREE
WOONSOCKET, R.I., Sept. 21, 2022 /PRNewswire/ -- CVS Health (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of fifty-five cents ($0.55) per share on the Common Stock of the Corporation. The dividend is payable on November 1, 2022, to holders of record on October 21, 2022.
About CVS Health
CVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses and nurse practitioners. Wherever and whenever people need us, we help them with their health – whether that's managing chronic diseases, staying compliant with their medications or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system – and their personal health care – by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cvs-health-announces-quarterly-dividend-301630321.html
SOURCE CVS Health Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 76.8% of Dojo Meditation Sessions Lowered Heart Rate in Early Wearable Analysis
- Long Island Personal Injury Lawyer Keetick L. Sanchez Announces New Freeport Office Serving Nassau County and Long Island
- CVS Health (CVS) PT Raised to $110 at BofA Securities
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share